Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
The ANNALS of the American Academy of Political and Social Science
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by JARLAIS, D. C. D.
Right arrow Articles by FRIEDMAN, S. R.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

AIDS and Legal Access to Sterile Drug Injection Equipment

DON C. DES JARLAIS

SAMUEL R. FRIEDMAN

Legal access to sterile injection equipment has been a primary strategy for preventing the acquired immune deficiency syndrome (AIDS) among persons who inject illicit drugs in almost all developed countries. This strategy has remained highly controversial in the United States, with only a small number of localities adopting it. This article reviews different techniques of providing legal access—over-the-counter sales and syringe exchanges—research design issues relevant to evaluating legal-access programs, and the findings from the large number of studies conducted to date. The findings are consistent in showing no increase in illicit drug use related to legal access and decreases in AIDS risk behavior related to legal-access programs. The design of legal-access programs for maximal impact and the ultimate effect of the decreases in AIDS risk behavior on transmission of the human immunodeficiency virus (HIV) remain to be determined.

The ANNALS of the American Academy of Political and Social Science, Vol. 521, No. 1, 42-65 (1992)
DOI: 10.1177/0002716292521001004
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J Law Med EthicsHome page
S. Loue, P. Lurie, and L. S. Lloyd
Ethical Issues Raised by Needle Exchange Programs
J. Law Med. Ethics, December 1, 1995; 23(4): 382 - 388.
[PDF]

Home page
 JAMAHome page
J. Stryker, T. J. Coates, P. DeCarlo, K. Haynes-Sanstad, M. Shriver, and H. J. Makadon
Prevention of HIV Infection: Looking Back, Looking Ahead
JAMA, April 12, 1995; 273(14): 1143 - 1148.
[Abstract] [PDF]

Home page
 JAMAHome page
D. C. D. Jarlais, D. Paone, S. R. Friedman, N. Peyser, and R. G. Newman
Regulating Syringe Exchange Programs: A Cautionary Note
JAMA, August 10, 1994; 272(6): 431 - 432.
[Abstract] [PDF]

Home page
 JAMAHome page
D. C. D. Jarlais, S. R. Friedman, J. L. Sotheran, J. Wenston, M. Marmor, S. R. Yancovitz, B. Frank, S. Beatrice, and D. Mildvan
Continuity and Change Within an HIV Epidemic: Injecting Drug Users in New York City, 1984 Through 1992
JAMA, January 12, 1994; 271(2): 121 - 127.
[Abstract] [PDF]